Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)

Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial‪)‬

Clinical Chemistry 1997, July, 43, 7

    • 3.0 • 1 Rating
    • $5.99
    • $5.99

Publisher Description

As part of the International Congress of Clinical Chemistry, a symposium, Doping in Sport: Misuse, Analytical Tests, and Legal Aspects, was held, a week before the start of the Olympic Games at Atlanta, bringing together a number of international experts concerned with various aspects of controlling drug abuse in sport. The presentations focused particularly on anabolic-androgenic steroids (AAS), these analytes still comprising the greatest number of positive findings in samples tested by International Olympic Committee (IOC)-accredited sports drug-testing laboratories. Although various aspects of AAS use and detection have been reported on in the last decade, the proceedings of this symposium, published in this issue of Clinical Chemistry, bring together health, social, endocrine, and analytical perspectives in a widely read peer-reviewed journal. Those who think that the harmful effects of AAS administration are relatively benign and perhaps should not be banned by the IOC may find particularly sobering the article by Franke and Berendonk [1], which describes the health and social consequences of the clandestine state-sponsored program of administration of AAS in the former East Germany. This article should be extremely useful for educational purposes and, we hope, will encourage some present users to abandon the practice. The mechanism of action of AAS is still not well understood, and the article by Wu [2] is a useful update. Catlin et al. [3] discuss the pertinent issues of detecting AAS administration, in particular of testosterone (T), which is commonly abused. Stenman et al. [4] give a clinical chemistry perspective on the problems of detecting human chorionic gonadotropin (hCG) by immunoassay, the protein hormone that may be used by competitors to stimulate testicular production of T. Bowers [5] discusses analytical advances to detect performance-enhancing compounds, particularly with reference to xenobiotic AAS and peptide hormones, such as hCG.

GENRE
Science & Nature
RELEASED
1997
July 1
LANGUAGE
EN
English
LENGTH
13
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
170.8
KB

More Books Like This

Doping, Performance-Enhancing Drugs, and Hormones in Sport Doping, Performance-Enhancing Drugs, and Hormones in Sport
2017
Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview) Point/Counterpoint: The Case Against Bioidentical Hormones (Drug Overview)
2008
Contemporary Practice in Clinical Chemistry Contemporary Practice in Clinical Chemistry
2020
Maximize Your Vitality & Potency for Men Over 40 Maximize Your Vitality & Potency for Men Over 40
1999
Principles of Pharmacogenetics and Pharmacogenomics Principles of Pharmacogenetics and Pharmacogenomics
2012
Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia
2021

More Books by Clinical Chemistry

Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs) Genetic Variation in the MTHFR Gene Influences Thiopurine Methyltransferase Activity (Technical Briefs)
2005
Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry) Ghrelin, Leptin, IGF-1, IGFBP-3, and Insulin Concentrations at Birth: Is There a Relationship with Fetal Growth and Neonatal Anthropometry?(Pediatric Clinical Chemistry)
2008
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
Transferrin Saturation and Screening of Genetic Hemochromatosis (Letters) (Letter to the Editor) Transferrin Saturation and Screening of Genetic Hemochromatosis (Letters) (Letter to the Editor)
1998
Effect of Riboflavin Status on the Homocysteine-Lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype (Nutrition) Effect of Riboflavin Status on the Homocysteine-Lowering Effect of Folate in Relation to the MTHFR (C677T) Genotype (Nutrition)
2003
Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine (Evidence-Based Laboratory Medicine and Test Utilization) Methodology in Diagnostic Laboratory Test Research in Clinical Chemistry and Clinical Chemistry and Laboratory Medicine (Evidence-Based Laboratory Medicine and Test Utilization)
2004